ZenTech is a biotechnology company specializing in the development and commercialization of In Vitro solutions and reagents. The tests are noninvasive and allow for neonatal screening as well as screening of rare, genetic, chronic or infectious metabolic diseases in human body fluid samples.
ZenTech/LaCAR Solutions
The newborn screening kit for hemoglobinopathy evaluation, Targeted MS/MS Hemo, is a qualitative analytical test for newborn screening for hemoglobin (Hb)-related conditions such as sickle cell disease. This test is based on the detection by mass spectrometry of peptides generated during the digestion of normal Hb and/or variants (HbA, HbA2, HbC, HbDPunjab/Los Angeles, HbE, HbF, HbOArab and HbS) of the patient.
Pathologies Detected:
- Alpha-thalassemias test
- Beta-thalassemias test
- Sickle cell disease or sickle cell trait screening – HbS
- Hemoglobin C or trait – HbC
- Asymptomatic or pathological composite heterozygosity for the following Hb variants: HbC, HbDPunjab/Los Angeles, HbE, HbF, HbOArab and HbS.
